Youcare Pharmaceutical Group Co., Ltd. (SHA:688658)
11.67
+0.03 (0.26%)
Nov 6, 2026, 10:25 AM CST
SHA:688658 Revenue
Youcare Pharmaceutical Group had revenue of 494.26M CNY in the quarter ending September 30, 2026, a decrease of -16.47%. This brings the company's total for the last twelve months to 2.36B, down -7.29% year-over-year. In the year 2025, Youcare Pharmaceutical Group had annual revenue of 2.45B, down -35.30%. That makes Youcare Pharmaceutical Group the 13,406th largest company in the world by revenue and 2,370th in China.
Revenue (ttm)
2.36B
Revenue Growth
-7.29%
P/S Ratio
2.19
Revenue / Employee
816.31K
Employees
2,894
Market Cap
5.19B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:688658 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.45B | -1.33B | -35.30% |
| Dec 31, 2024 | 3.78B | -415.42M | -9.90% |
| Dec 31, 2023 | 4.20B | -345.64M | -7.61% |
| Dec 31, 2022 | 4.54B | -423.78M | -8.53% |
| Dec 31, 2021 | 4.97B | 626.78M | 14.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ChemPartner PharmaTech | 1.27B |
| Shenzhen Weiguang Biological Products | 1.13B |
| Boji Medical Technology | 1.02B |
| R&G PharmaStudies | 957.42M |
| Wuhan Keqian Biology Co.,Ltd | 786.77M |
| Zhejiang Ausun Pharmaceutical | 757.05M |
| PharmaResources (Shanghai) | 724.75M |
| Jiangsu Aidea Pharmaceutical Group | 716.78M |